Australis Pharmaceuticals

Australis Pharmaceuticals develops cancer treatments that prioritize safety, efficacy, and access. We are driven by the urgent need to minimize suffering among cancer patients with a better alternative to traditional treatments. Our compound, AUS_001, offers hope and has shown encouraging pre-clinical data in treating 24 types of cancer with few side effects in these pre-clinical models. We focus on therapies derived from natural compounds, targeting aggressive and hard-to-treat cancers where current options are limited. Our goal is to improve outcomes for patients by bringing forward treatments that are not only effective, but also tolerable and accessible. We’re driven by a simple aim: to turn scientific progress into practical, accessible solutions for patients who need them most. Learn more here: australispharma.com